Index DJIA, NDX, S&P 500
P/E -
EPS (ttm) -3.64
Insider Own 0.30%
Shs Outstand 862.60M
Perf Week 0.74%
Market Cap 27.48B
Forward P/E 6.62
EPS next Y 4.75
Insider Trans 0.40%
Shs Float 714.48M
Perf Month -0.54%
Income -3144.00M
PEG -
EPS next Q 1.09
Inst Own 59.80%
Short Float / Ratio 4.76% / 4.73
Perf Quarter -5.53%
Sales 133.29B
P/S 0.21
EPS this Y 117.60%
Inst Trans -0.06%
Short Interest 34.00M
Perf Half Y -22.71%
Book/sh 24.57
P/B 1.28
EPS next Y 5.96%
ROA -3.30%
Target Price 40.00
Perf Year -26.24%
Cash/sh 2.10
P/C 14.93
EPS next 5Y 1.73%
ROE -13.50%
52W Range 29.48 - 42.74
Perf YTD -15.90%
Dividend 1.92
P/FCF -
EPS past 5Y 5.80%
ROI 4.60%
52W High -26.49%
Beta 0.72
Dividend % 6.11%
Quick Ratio 0.30
Sales past 5Y 2.30%
Gross Margin 20.20%
52W Low 6.58%
ATR 0.75
Employees 200000
Current Ratio 0.60
Sales Q/Q 3.30%
Oper. Margin -6.00%
RSI (14) 47.17
Volatility 2.35% 2.22%
Optionable Yes
Debt/Eq 0.66
EPS Q/Q -20.20%
Profit Margin -2.40%
Rel Volume 0.87
Prev Close 31.85
Shortable Yes
LT Debt/Eq 0.46
Earnings Jun 27 BMO
Payout 38.21%
Avg Volume 7.19M
Price 31.42
Recom 2.90
SMA20 1.06%
SMA50 -5.28%
SMA200 -11.43%
Volume 6,227,038
Change -1.35%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade
Deutsche Bank
Sell → Hold
$51 → $43
Dec-11-19 Downgrade
Wells Fargo
Outperform → Market Perform
$65 → $61
Oct-30-19 Reiterated
Pivotal Research Group
Hold
$60 → $55
Oct-23-19 Downgrade
JP Morgan
Overweight → Neutral
$73 → $63
Sep-27-19 Resumed
RBC Capital Mkts
Sector Perform
$59
Sep-12-19 Initiated
Deutsche Bank
Sell
Apr-18-19 Initiated
Guggenheim
Neutral
$59
Apr-03-19 Reiterated
Pivotal Research Group
Hold
$70 → $60
Show Previous Ratings
Jun-10-23 05:00AM
Jun-09-23 07:51PM
01:05PM
11:33AM
10:53AM
05:21AM
Loading…
05:21AM
Jun-08-23 08:33PM
02:00PM
01:00PM
09:11AM
Jun-07-23 05:45PM
04:38PM
01:21PM
09:33AM
05:55AM
12:00PM
Loading…
Jun-06-23 12:00PM
Jun-05-23 10:31AM
09:00AM
Jun-02-23 10:26AM
Jun-01-23 05:45PM
10:15AM
10:00AM
09:00AM
May-31-23 08:30AM (American City Business Journals)
May-29-23 07:30PM
10:00AM
May-26-23 05:45PM
05:01PM
12:16PM
09:52AM
05:50AM
Loading…
05:50AM
05:21AM
May-25-23 08:26AM
May-23-23 04:49PM
11:17AM
May-22-23 12:31PM
12:29PM
May-21-23 09:00AM
May-19-23 05:40AM
May-18-23 05:45PM
05:26PM
11:41AM
10:39AM
09:15AM
07:00AM
05:56AM
05:45AM
04:19AM
May-17-23 02:47PM
02:29PM
08:48AM
May-16-23 09:12AM
May-15-23 02:56PM
May-11-23 11:26PM
11:21PM
10:13PM
05:45PM
12:37PM
May-10-23 03:39PM
03:39PM
11:18AM
05:15AM
May-08-23 03:56PM
May-06-23 05:30AM
May-05-23 05:45PM
May-03-23 07:11PM
04:52PM
11:59AM
05:06AM
May-02-23 09:00AM
Apr-28-23 09:53AM
09:15AM
Apr-27-23 11:30AM
08:30AM
05:46AM
Apr-26-23 07:00AM
05:20AM
Apr-25-23 02:25PM
06:10AM
05:00AM
Apr-24-23 02:31PM
10:58AM
Apr-21-23 12:16PM
10:00AM
Apr-20-23 11:29AM
05:06AM
Apr-19-23 09:00AM (The Wall Street Journal)
Apr-17-23 10:31AM
09:00AM
Apr-16-23 10:24AM
Apr-14-23 09:37AM
07:30AM
Apr-13-23 08:00AM
05:06AM
Apr-12-23 08:00AM
Apr-11-23 09:20AM
Apr-10-23 12:33PM
10:24AM
09:00AM
08:56AM
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner May 11 Sale 170.77 292,792 50,000,090 33,366,388 May 15 05:18 PM BREWER ROSALIND G CEO Mar 29 Buy 33.95 10,000 339,510 369,945 Mar 31 04:26 PM Walgreens Boots Alliance, Inc. 10% Owner Mar 01 Sale 30.30 15,475,166 468,897,530 10,771,926 Mar 03 04:43 PM Walgreens Boots Alliance, Inc. 10% Owner Dec 08 Sale 165.08 5,961,534 984,130,033 33,659,180 Dec 12 05:26 PM Ban Kevin M. EVP, Chief Medical Officer Nov 18 Option Exercise 34.04 10,303 350,714 38,219 Nov 22 08:20 PM Ban Kevin M. EVP, Chief Medical Officer Nov 18 Sale 40.19 10,303 414,108 27,916 Nov 22 08:20 PM SCHLICHTING NANCY M Director Nov 17 Sale 39.89 16,570 660,928 5,515 Nov 21 06:11 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 07 Sale 154.60 13,234,153 2,046,000,054 39,629,714 Nov 09 08:00 AM Walgreens Boots Alliance, Inc. 10% Owner Aug 16 Sale 33.01 11,000,000 363,110,000 26,247,092 Aug 18 04:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite